176 related articles for article (PubMed ID: 22395225)
1. Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case series.
Barreiro-de Acosta M; García-Bosch O; Gordillo J; Mañosa M; Menchén L; Souto R; Marin-Jimenez I;
Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):756-8. PubMed ID: 22395225
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study.
Barreiro-de Acosta M; García-Bosch O; Souto R; Mañosa M; Miranda J; García-Sanchez V; Gordillo J; Chacon S; Loras C; Carpio D; Maroto N; Menchén L; Rojas-Feria M; Sierra M; Villoria A; Marin-Jimenez I;
Inflamm Bowel Dis; 2012 May; 18(5):812-7. PubMed ID: 21826765
[TBL] [Abstract][Full Text] [Related]
3. Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience.
Verstockt B; Claeys C; De Hertogh G; Van Assche G; Wolthuis A; D'Hoore A; Vermeire S; Ferrante M
United European Gastroenterol J; 2019 Nov; 7(9):1215-1225. PubMed ID: 31700634
[TBL] [Abstract][Full Text] [Related]
4. Clinical Features of Refractory Pouchitis with Penetrating Lesions and the Efficacy of Infliximab Treatment for Patients with Ulcerative Colitis after Restorative Proctocolectomy.
Uchino M; Ikeuchi H; Bando T; Hirose K; Hirata A; Chohno T; Sasaki H; Horio Y; Takahashi Y; Takesue Y; Hida N; Hori K; Nakamura S
Digestion; 2015; 92(3):147-55. PubMed ID: 26343749
[TBL] [Abstract][Full Text] [Related]
5. Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab.
Taxonera C; Estellés J; Fernández-Blanco I; Merino O; Marín-Jiménez I; Barreiro-de Acosta M; Saro C; García-Sánchez V; Gento E; Bastida G; Gisbert JP; Vera I; Martinez-Montiel P; Garcia-Morán S; Sánchez MC; Mendoza JL
Aliment Pharmacol Ther; 2011 Feb; 33(3):340-8. PubMed ID: 21133961
[TBL] [Abstract][Full Text] [Related]
6. Cost-per-remission analysis of infliximab compared to adalimumab among adults with moderate-to-severe ulcerative colitis.
Lofland JH; Mallow P; Rizzo J
J Med Econ; 2013; 16(4):461-7. PubMed ID: 23445401
[TBL] [Abstract][Full Text] [Related]
7. Adalimumab and infliximab are equally effective for Crohn's disease in patients not previously treated with anti-tumor necrosis factor-α agents.
Kestens C; van Oijen MG; Mulder CL; van Bodegraven AA; Dijkstra G; de Jong D; Ponsioen C; van Tuyl BA; Siersema PD; Fidder HH; Oldenburg B;
Clin Gastroenterol Hepatol; 2013 Jul; 11(7):826-31. PubMed ID: 23376000
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
[TBL] [Abstract][Full Text] [Related]
9. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis.
Calabrese C; Gionchetti P; Rizzello F; Liguori G; Gabusi V; Tambasco R; Poggioli G; Pierangeli F; Campieri M; Di Febo G
Aliment Pharmacol Ther; 2008 May; 27(9):759-64. PubMed ID: 18298639
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry.
Zannin ME; Birolo C; Gerloni VM; Miserocchi E; Pontikaki I; Paroli MP; Bracaglia C; Shardlow A; Parentin F; Cimaz R; Simonini G; Falcini F; Corona F; Viola S; De Marco R; Breda L; La Torre F; Vittadello F; Martini G; Zulian F
J Rheumatol; 2013 Jan; 40(1):74-9. PubMed ID: 23118110
[TBL] [Abstract][Full Text] [Related]
11. One year of infliximab therapy successfully improved a case of refractory pouchitis without the use of antibiotics.
Iizuka M; Etou T; Yagisawa H; Ishii T; Sagara S
Intern Med; 2014; 53(22):2581-3. PubMed ID: 25400178
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Adalimumab in Ulcerative Colitis Refractory to Conventional Therapy in Routine Clinical Practice.
Bálint A; Farkas K; Palatka K; Lakner L; Miheller P; Rácz I; Hegede G; Vincze Á; Horváth G; Szabó A; Nagy F; Szepes Z; Gábor Z; Zsigmond F; Zsóri Á; Juhász M; Csontos Á; Szűcs M; Bor R; Milassin Á; Rutka M; Molnár T
J Crohns Colitis; 2016 Jan; 10(1):26-30. PubMed ID: 26392413
[TBL] [Abstract][Full Text] [Related]
13. Management of refractory fistulizing pouchitis with infliximab.
Viscido A; Kohn A; Papi C; Caprilli R
Eur Rev Med Pharmacol Sci; 2004; 8(5):239-46. PubMed ID: 15638238
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experience.
Teisner AS; Ainsworth MA; Brynskov J
Scand J Gastroenterol; 2010 Dec; 45(12):1457-63. PubMed ID: 20701434
[TBL] [Abstract][Full Text] [Related]
15. Oral budesonide in the treatment of chronic refractory pouchitis.
Gionchetti P; Rizzello F; Poggioli G; Pierangeli F; Laureti S; Morselli C; Tambasco R; Calabrese C; Campieri M
Aliment Pharmacol Ther; 2007 May; 25(10):1231-6. PubMed ID: 17451569
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series.
Ferrante M; D'Haens G; Dewit O; Baert F; Holvoet J; Geboes K; De Hertogh G; Van Assche G; Vermeire S; Rutgeerts P;
Inflamm Bowel Dis; 2010 Feb; 16(2):243-9. PubMed ID: 19637335
[TBL] [Abstract][Full Text] [Related]
17. Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab.
Favale A; Onali S; Caprioli F; Pugliese D; Armuzzi A; Macaluso FS; Orlando A; Viola A; Fries W; Rispo A; Castiglione F; Mocci G; Chicco F; Usai P; Calabrese E; Biancone L; Monteleone G; Fantini MC;
Inflamm Bowel Dis; 2019 Oct; 25(11):1805-1812. PubMed ID: 30931477
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn's disease patients in primary gastroenterology centres.
Tursi A; Elisei W; Picchio M; Penna A; Lecca PG; Forti G; Giorgetti G; Faggiani R; Zampaletta C; Pelecca G; Brandimarte G
Eur J Intern Med; 2014 Jun; 25(5):485-90. PubMed ID: 24631020
[TBL] [Abstract][Full Text] [Related]
19. [A case of refractory pouchitis following surgery for ulcerative colitis successfully treated with adalimumab].
Kato S; Sakakibara Y; Ishihara A; Iwasaki T; Tanaka S; Hasegawa H; Akasaka T; Nakazuru S; Ishida H; Mita E
Nihon Shokakibyo Gakkai Zasshi; 2019; 116(9):732-738. PubMed ID: 31511459
[TBL] [Abstract][Full Text] [Related]
20. Infliximab rescue therapy after cyclosporin failure in steroid-refractory ulcerative colitis.
Mañosa M; López San Román A; Garcia-Planella E; Bastida G; Hinojosa J; Gonzalez-Lama Y; Masnou H; Domènech E
Digestion; 2009; 80(1):30-5. PubMed ID: 19439969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
